Representative participants include Elekta, Varian, Accuray, Brainlab, RaySearch, MIM Software, Philips Healthcare, GE HealthCare, Siemens Healthineers, CIVCO, Prowess, and LAP GmbH.

Premium integrated systems with multi-modality image fusion, AI-assisted auto-segmentation, and cloud-based planning account for a substantial share of new shipments by value, while standard configurations target price-sensitive tenders in emerging markets.

The global Radiosurgery Planning System market is expanding, with an installed base estimated between 5,500 and 7,000 stereotactic radiosurgery platforms, fueling ongoing demand for upgrades and replacements every 5–8 years.

Forecasts show steady market growth through 2035, propelled by AI integration, an aging base, and expanding radiotherapy capacity, with 2025 market value around USD 1.2 billion and a 2035 value projected above USD 2.2 billion.

Replacement cycles for Gamma Knife and Linac-based systems create recurring demand for planning software and hardware modules, contributing to sustained market expansion.

Import dependence remains high outside North America and Western Europe, with 60–75% of hardware and components sourced from a limited set of specialized electronics suppliers.

Premium planning solutions with AI-driven contouring drive significant value capture, whereas standard-grade configurations dominate unit volumes in emerging markets.

Regulatory and cybersecurity requirements, including FDA 510(k), MDR/ISO 13485, and IEC standards, create high barriers for market access and AI-module validation.

Cloud-enabled distributed planning and optional cloud infrastructure are increasingly included in procurements, with an estimated 20–30% of 2026–2027 purchases enabling cloud-based distributed workflows.

Asia-Pacific is the fastest-growing region, led by China, India, and South Korea, while North America and Western Europe remain dominant in value and replacement activity, with regional dynamics showing 32% growth in Asia-Pacific and 30% in North America.

The market faces challenges from price pressure in public tenders, high upfront costs for premium systems, regulatory certification timelines, GPU/HPC supply volatility, and skilled personnel shortages in emerging regions.

The market remains competitive but concentrated, with major radiotherapy vendors offering integrated planning while independent software and electronics players compete on AI capabilities, interoperability, and service networks.